Company Information
CIN
Status
Date of Incorporation
28 November 2013
State / ROC
Hyderabad / ROC Hyderabad
Industry
allopathic pharmaceutical
Sub Category
Non-govt company
Last Balance Sheet
Last Annual Meeting
Paid Up Capital
500,000
Authorised Capital
500,000
Directors
Past Directors
Patents
ABSTRACT
The present invention provide a dynamic kinetic resolution process for Clopidogrel utilizing racemisation of optically active isomer of 2-halo-2-(2-chlorophenyl) acetic acid methyl ester of formula (I). More particularly the present invention relates to S (+) 2-bromo-2-(2-chlorophenyl) acetic acid methyl...
The present invention relates to an improved process for the preparation of Micafungin sodium of a Compound of Formula (I), by treating Micafungin or its base addition salt with sodium salt longer fatty acids.
The present invention relates to an improved process for the preparation of Caspofungin acetate of a Compound of Formula (II) and Pneumocandin BO of a Compound of Formula (I), which is a key intermediate in the synthesis of Caspofungin acetate of a Compound of Formula (II).
The present invention relates to a process for the purification of Sacrosidase, which comprises elution of crude Sacrosidase solution on an anion exchange chromatography, a hydrophobic interaction chromatography, and then an ultrafiltration to obtain purified Sacrosidase.
Trademarks
[Class : 42] Medical And Pharmaceutical Research, Design And Development Services; Pharmaceutical Drug Development Services For Third Parties; Pharmaceutical Services, Namely Conducting Clinical Trials, Monitoring Clinical Trials And Drug Development To Ensure That Certification Requirements Are Met; Testing Services In The Field Of Drug Compatibility; Consultancy Services I...
